184 related articles for article (PubMed ID: 9113504)
21. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas.
Mugitani A; Tatsumi Y; Tanaka K; Yasui Y; Inoue T
Anticancer Res; 1999; 19(4C):3393-7. PubMed ID: 10629625
[TBL] [Abstract][Full Text] [Related]
25. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
[TBL] [Abstract][Full Text] [Related]
26. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
27. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
Hehn ST; Miller TP
Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
[TBL] [Abstract][Full Text] [Related]
28. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
29. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
30. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
Gisselbrecht C; Oksenjendler E; Tirelli U; Gabarre J; Gastaldi R; Farcet JP; Thyss A; Coiffier B; Raphael M; Lepage E
Leukemia; 1992; 6 Suppl 3():10S-11S. PubMed ID: 1376380
[No Abstract] [Full Text] [Related]
32. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis.
Martinelli G; Cocorocchio E; Peccatori F; Zucca E; Saletti PC; Calabrese L; Pastano R; Pruneri G; Mazzetta C; Ghielmini M; Cavalli F
Br J Haematol; 2004 Jun; 125(5):584-9. PubMed ID: 15147373
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor.
Hernàndez DE; Hernàndez AE
Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909
[TBL] [Abstract][Full Text] [Related]
34. Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas.
Cheson BD; Feigal EG
Oncology (Williston Park); 1993 Apr; 7(4):37-8. PubMed ID: 7683481
[No Abstract] [Full Text] [Related]
35. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
Gabarre J; Leblond V; Sutton L; Azar N; Jouan M; Boccaccio C; Gonzalez H; Charlotte F; Gentilini M; Binet JL
Bone Marrow Transplant; 1996 Dec; 18(6):1195-7. PubMed ID: 8971396
[TBL] [Abstract][Full Text] [Related]
36. [Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Kaźmierczak M; Komarnicki M; Kroll R
Acta Haematol Pol; 1995; 26(3):311-3. PubMed ID: 8525778
[TBL] [Abstract][Full Text] [Related]
37. [C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)].
Ino T; Okamoto M; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Takada T; Morikawa K
Rinsho Ketsueki; 1987 Jun; 28(6):839-44. PubMed ID: 3669323
[No Abstract] [Full Text] [Related]
38. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T
Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470
[No Abstract] [Full Text] [Related]
39. [Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program].
Bogusławska-Jaworska J; Grześkowiak-Melanowska J; Kaczmarek M; Kościelniak E; Legutko L; Sońta-Jakimczyk D; Sroczyńska M; Wojcik Z
Pediatr Pol; 1980 Feb; 55(2):207-10. PubMed ID: 6154919
[No Abstract] [Full Text] [Related]
40. [Dysfunction of the blood-brain barrier in patients with acute leukemias or lymphomas of high grade malignancy].
Zdziarska B; Nowacki P; Millo B
Acta Haematol Pol; 1995; 26(3):299-304. PubMed ID: 8525776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
